Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Baxter
Johnson and Johnson
AstraZeneca
Harvard Business School

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Patent: 8,815,246

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,815,246
Title:Fc receptor binding proteins
Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
Inventor(s): TenHoor; Christopher (Hopkinton, MA), Muruganandam; Arumugam (Bangalore, IN), Ladner; Robert Charles (Ijamsville, MD), Wood; Clive (Boston, MA), Bitonti; Alan J. (Acton, MA), Stattel; James (Hagerstown, MD), McDonnell; Kevin (Waltham, MA), Liu; Liming (Upper Dublin, PA), Dumont; Jennifer (Groton, MA), Sato; Aaron K. (Richmond, CA), Viswanathan; Malini (Burlington, MA)
Assignee: Dyax Corp. (Cambridge, MA) Syntonix Pharmaceuticals, Inc. (Waltham, MA)
Application Number:13/617,498
Patent Claims:see list of patent claims

Details for Patent 8,815,246

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23   Start Trial Dyax Corp. (Cambridge, MA) Syntonix Pharmaceuticals, Inc. (Waltham, MA) 2028-04-25 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,815,246

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
McKinsey
Johnson and Johnson
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.